ULTRALUTE Trademark

Trademark Overview

On Tuesday, October 1, 2019, a trademark application was filed for ULTRALUTE with the United States Patent and Trademark Office. The USPTO has given the ULTRALUTE trademark a serial number of 79273236. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by Cyclomedica Australia Pty Ltd. The ULTRALUTE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, apparatus and instruments for delivery of radiation in the nuclear medicine and clinical laboratory markets; medical devices for capturing radioisotopes
ultralute

General Information

Serial Number79273236
Word MarkULTRALUTE
Filing DateTuesday, October 1, 2019
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6224393
Registration DateTuesday, December 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Pseudo MarkULTRA LUTE
Goods and ServicesMedical devices, apparatus and instruments for delivery of radiation in the nuclear medicine and clinical laboratory markets; medical devices for capturing radioisotopes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, December 17, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCyclomedica Australia Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameCyclomedica Australia Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameCyclomedica Australia Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Thursday, December 5, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 16, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, December 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 21, 2019APPLICATION FILING RECEIPT MAILED
Friday, January 3, 2020ASSIGNED TO EXAMINER
Wednesday, January 8, 2020NON-FINAL ACTION WRITTEN
Thursday, January 9, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 4, 2020REFUSAL PROCESSED BY MPU
Tuesday, February 4, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 22, 2020REFUSAL PROCESSED BY IB
Tuesday, August 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, October 25, 2020NOTIFICATION PROCESSED BY IB
Friday, October 30, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Monday, March 22, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 29, 2021FINAL DISPOSITION PROCESSED
Monday, March 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, April 18, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 22, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Related Keywords

ultralute medical devices laboratory markets capturing radioisotopes clinical nuclear apparatus instruments